Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1201

1.

Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Jun 11;10(1):2644. doi: 10.1038/s41467-019-10790-0.

2.

Sequential open label study of the safety, tolerability and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults.

Hanboonkunupakarn B, van der Pluijm RW, Hoglund R, Pukrittayakamee S, Winterberg M, Mukaka M, Waithira N, Chotivanich K, Singhasivanon P, White NJ, Dondorp AM, Tarning J, Jittamala P.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00060-19. doi: 10.1128/AAC.00060-19. [Epub ahead of print]

3.

Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

Saralamba N, Nosten F, Sutherland CJ, Arez AP, Snounou G, White NJ, Day NPJ, Dondorp AM, Imwong M.

PLoS One. 2019 Jun 6;14(6):e0217795. doi: 10.1371/journal.pone.0217795. eCollection 2019.

4.

Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self-propelling particles.

Baylis JR, Lee MM, St John AE, Wang X, Simonson E, Cau M, Kazerooni A, Gusti V, Statz ML, Yoon JSJ, Liggins RT, White NJ, Kastrup CJ.

J Thromb Haemost. 2019 May 30. doi: 10.1111/jth.14526. [Epub ahead of print]

PMID:
31145837
5.

The contribution of functional antimalarial immunity to measures of parasite clearance in therapeutic efficacy studies of artemisinin derivatives.

O'Flaherty K, Ataíde R, Zaloumis SG, Ashley EA, Powell R, Feng G, Reiling L, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJI.

J Infect Dis. 2019 May 10. pii: jiz247. doi: 10.1093/infdis/jiz247. [Epub ahead of print]

PMID:
31075171
6.

Amino acid derangements in adults with severe falciparum malaria.

Leopold SJ, Apinan S, Ghose A, Kingston HW, Plewes KA, Hossain A, Dutta AK, Paul S, Barua A, Sattar A, Day NPJ, Tarning J, Winterberg M, White NJ, Dondorp AM.

Sci Rep. 2019 Apr 29;9(1):6602. doi: 10.1038/s41598-019-43044-6.

7.

Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study.

Adhikari B, Phommasone K, Pongvongsa T, Koummarasy P, Soundala X, Henriques G, Sirithiranont P, Parker DM, von Seidlein L, White NJ, Day NPJ, Dondorp AM, Newton PN, Cheah PY, Pell C, Mayxay M.

BMC Health Serv Res. 2019 Apr 24;19(1):252. doi: 10.1186/s12913-019-4070-9.

8.

Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations.

Parker DM, Tun STT, White LJ, Kajeechiwa L, Thwin MM, Landier J, Chaumeau V, Corbel V, Dondorp AM, von Seidlein L, White NJ, Maude RJ, Nosten F.

Elife. 2019 Apr 16;8. pii: e41023. doi: 10.7554/eLife.41023.

9.

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, Thinraow S, Wilairisak P, Raksapraidee R, Carrara VI, Paw MK, Wiladphaingern J, Proux S, Bancone G, Sriprawat K, Lee SJ, Jeeyapant A, Watson J, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2019 Apr 8;68(8):1311-1319. doi: 10.1093/cid/ciy735.

10.

Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia.

Duanguppama J, Mathema VB, Tripura R, Day NPJ, Maxay M, Nguon C, von Seidlein L, Dhorda M, Peto TJ, Nosten F, White NJ, Dondorp AM, Imwong M.

Malar J. 2019 Apr 2;18(1):114. doi: 10.1186/s12936-019-2749-3.

11.

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Mar 29;10(1):1433. doi: 10.1038/s41467-019-09441-1. Erratum in: Nat Commun. 2019 Jun 11;10(1):2644.

12.

Does reduced oxygen delivery cause lactic acidosis in falciparum malaria? An observational study.

Kingston HW, Ghose A, Rungpradubvong V, Herdman MT, Plewes K, Ishioka H, Leopold SJ, Maude RJ, Intharabut B, Mohanty S, Day NPJ, White NJ, Hossain MA, Anstey NM, Dondorp AM.

Malar J. 2019 Mar 25;18(1):97. doi: 10.1186/s12936-019-2733-y.

13.

Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region.

Pell CL, Adhikari B, Myo Thwin M, Kajeechiwa L, Nosten S, Nosten FH, Sahan KM, Smithuis FM, Nguyen TN, Hien TT, Tripura R, Peto TJ, Sanann N, Nguon C, Pongvongsa T, Phommasone K, Mayxay M, Mukaka M, Peerawaranun P, Kaehler N, Cheah PY, Day NPJ, White NJ, Dondorp AM, von Seidlein L.

PLoS One. 2019 Mar 25;14(3):e0214280. doi: 10.1371/journal.pone.0214280. eCollection 2019.

14.

Surgical outcomes of chronic isolated scapholunate interosseous ligament injuries: a systematic review of 805 wrists

Montgomery SJ, Rollick NJ, Kubik JF, Meldrum AR, White NJ.

Can J Surg. 2019 Mar 22;62(3):1-12. [Epub ahead of print]

PMID:
30900438
15.
16.

Efficacy of primaquine in preventing short and long latency Plasmodium vivax relapses in Nepal.

Rijal KR, Adhikari B, Ghimire P, Banjara MR, Thakur GD, Hanboonkunupakarn B, Imwong M, Chotivanich K, Day NPJ, White NJ, Pukrittayakamee S.

J Infect Dis. 2019 Mar 18. pii: jiz126. doi: 10.1093/infdis/jiz126. [Epub ahead of print]

PMID:
30882150
17.

Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk.

Ting LH, Feghhi S, Taparia N, Smith AO, Karchin A, Lim E, John AS, Wang X, Rue T, White NJ, Sniadecki NJ.

Nat Commun. 2019 Mar 13;10(1):1204. doi: 10.1038/s41467-019-09150-9.

18.

The rise and fall of long-latency Plasmodium vivax.

White NJ.

Trans R Soc Trop Med Hyg. 2019 Apr 1;113(4):163-168. doi: 10.1093/trstmh/trz002.

19.

Platelets retain inducible alpha granule secretion by P-selectin expression but exhibit mechanical dysfunction during trauma-induced coagulopathy.

St John AE, Newton JC, Martin EJ, Mohammed BM, Contaifer D Jr, Saunders JL, Brophy GM, Spiess BD, Ward KR, Brophy DF, López JA, White NJ.

J Thromb Haemost. 2019 May;17(5):771-781. doi: 10.1111/jth.14414. Epub 2019 Mar 18.

PMID:
30784176
20.

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.

von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, Nosten S, Proux S, Corbel V, Tuong-Vy N, Phuc-Nhi TL, Son DH, Huong-Thu PN, Tuyen NTK, Tien NT, Dong LT, Hue DV, Quang HH, Nguon C, Davoeung C, Rekol H, Adhikari B, Henriques G, Phongmany P, Suangkanarat P, Jeeyapant A, Vihokhern B, van der Pluijm RW, Lubell Y, White LJ, Aguas R, Promnarate C, Sirithiranont P, Malleret B, Rénia L, Onsjö C, Chan XH, Chalk J, Miotto O, Patumrat K, Chotivanich K, Hanboonkunupakarn B, Jittmala P, Kaehler N, Cheah PY, Pell C, Dhorda M, Imwong M, Snounou G, Mukaka M, Peerawaranun P, Lee SJ, Simpson JA, Pukrittayakamee S, Singhasivanon P, Grobusch MP, Cobelens F, Smithuis F, Newton PN, Thwaites GE, Day NPJ, Mayxay M, Hien TT, Nosten FH, Dondorp AM, White NJ.

PLoS Med. 2019 Feb 15;16(2):e1002745. doi: 10.1371/journal.pmed.1002745. eCollection 2019 Feb.

21.

Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.

Ashley EA, Phyo AP, Carrara VI, Tun KM, Nosten F, Smithuis F, White NJ.

J Infect Dis. 2019 Jun 5;220(1):100-104. doi: 10.1093/infdis/jiz052.

22.

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.

Chotsiri P, Zongo I, Milligan P, Compaore YD, Somé AF, Chandramohan D, Hanpithakpong W, Nosten F, Greenwood B, Rosenthal PJ, White NJ, Ouédraogo JB, Tarning J.

Nat Commun. 2019 Jan 29;10(1):480. doi: 10.1038/s41467-019-08297-9.

23.

Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.

Watson JA, Leopold SJ, Simpson JA, Day NP, Dondorp AM, White NJ.

Elife. 2019 Jan 28;8. pii: e43154. doi: 10.7554/eLife.43154.

24.

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole.

Watson JA, Strub-Wourgraft N, Tarral A, Ribeiro I, Tarning J, White NJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02515-18. doi: 10.1128/AAC.02515-18. Print 2019 Apr.

25.

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.

Intharabut B, Kingston HW, Srinamon K, Ashley EA, Imwong M, Dhorda M, Woodrow C, Stepniewska K, Silamut K, Day NPJ, Dondorp AM, White NJ; Tracking Resistance to Artemisinin Collaboration.

J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673. Erratum in: J Infect Dis. 2019 Jun 5;220(1):179.

26.

Tafenoquine - A Radical Improvement?

White NJ.

N Engl J Med. 2019 Jan 17;380(3):285-286. doi: 10.1056/NEJMe1816383. No abstract available.

PMID:
30650321
27.

Martial arts technique for control of severe external bleeding.

Slevin JP, Harrison C, Da Silva E, White NJ.

Emerg Med J. 2019 Mar;36(3):154-158. doi: 10.1136/emermed-2018-207966. Epub 2019 Jan 5.

PMID:
30612092
28.

Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.

Loesbanluechai D, Kotanan N, de Cozar C, Kochakarn T, Ansbro MR, Chotivanich K, White NJ, Wilairat P, Lee MCS, Gamo FJ, Sanz LM, Chookajorn T, Kümpornsin K.

Int J Parasitol Drugs Drug Resist. 2019 Apr;9:16-22. doi: 10.1016/j.ijpddr.2018.11.004. Epub 2018 Dec 1.

29.

Identifying the Components of Acidosis in Patients With Severe Plasmodium falciparum Malaria Using Metabolomics.

Leopold SJ, Ghose A, Allman EL, Kingston HWF, Hossain A, Dutta AK, Plewes K, Chotivanich K, Day NPJ, Tarning J, Winterberg M, White NJ, Llinás M, Dondorp AM.

J Infect Dis. 2019 May 5;219(11):1766-1776. doi: 10.1093/infdis/jiy727.

30.

Point-of-care lung ultrasound for the detection of pulmonary manifestations of malaria and sepsis: An observational study.

Leopold SJ, Ghose A, Plewes KA, Mazumder S, Pisani L, Kingston HWF, Paul S, Barua A, Sattar MA, Huson MAM, Walden AP, Henwood PC, Riviello ED, Schultz MJ, Day NPJ, Kumar Dutta A, White NJ, Dondorp AM.

PLoS One. 2018 Dec 12;13(12):e0204832. doi: 10.1371/journal.pone.0204832. eCollection 2018.

31.

Perceptions of asymptomatic malaria infection and their implications for malaria control and elimination in Laos.

Adhikari B, Phommasone K, Pongvongsa T, Soundala X, Koummarasy P, Henriques G, Peto TJ, Seidlein LV, White NJ, Day NPJ, Dondorp AM, Newton PN, Cheah PY, Mayxay M, Pell C.

PLoS One. 2018 Dec 11;13(12):e0208912. doi: 10.1371/journal.pone.0208912. eCollection 2018.

32.

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background.

Zhu L, Tripathi J, Rocamora FM, Miotto O, van der Pluijm R, Voss TS, Mok S, Kwiatkowski DP, Nosten F, Day NPJ, White NJ, Dondorp AM, Bozdech Z; Tracking Resistance to Artemisinin Collaboration I.

Nat Commun. 2018 Dec 4;9(1):5158. doi: 10.1038/s41467-018-07588-x.

33.

Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar.

Chaumeau V, Kajeechiwa L, Fustec B, Landier J, Naw Nyo S, Nay Hsel S, Phatharakokordbun P, Kittiphanakun P, Nosten S, Thwin MM, Win Tun S, Wiladphaingern J, Cottrell G, Parker DM, Minh MC, Kwansomboon N, Metaane S, Montazeau C, Kunjanwong K, Sawasdichai S, Andolina C, Ling C, Haohankhunnatham W, Christiensen P, Wanyatip S, Konghahong K, Cerqueira D, Imwong M, Dondorp AM, Chareonviriyaphap T, White NJ, Nosten FH, Corbel V.

J Infect Dis. 2019 Apr 16;219(9):1499-1509. doi: 10.1093/infdis/jiy686.

34.

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.

Puaprasert K, Chu C, Saralamba N, Day NPJ, Nosten F, White NJ, Dondorp AM, Imwong M.

Malar J. 2018 Nov 15;17(1):427. doi: 10.1186/s12936-018-2579-8.

35.

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review.

Haeusler IL, Chan XHS, Guérin PJ, White NJ.

BMC Med. 2018 Nov 7;16(1):200. doi: 10.1186/s12916-018-1188-2.

36.

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.

Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, Mukaka M, Peerawaranun P, von Seidlein L, Day NPJ, White NJ, Dondorp AM, Imwong M, Newton PN, Singhasivanon P, Mayxay M, Pukrittayakamee S.

Malar J. 2018 Nov 3;17(1):405. doi: 10.1186/s12936-018-2541-9.

37.

Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar.

McLean ARD, Wai HP, Thu AM, Khant ZS, Indrasuta C, Ashley EA, Kyaw TT, Day NPJ, Dondorp A, White NJ, Smithuis FM.

BMC Med. 2018 Oct 22;16(1):183. doi: 10.1186/s12916-018-1172-x.

38.

Anaemia and malaria.

White NJ.

Malar J. 2018 Oct 19;17(1):371. doi: 10.1186/s12936-018-2509-9. Review.

39.

Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi.

Imwong M, Madmanee W, Suwannasin K, Kunasol C, Peto TJ, Tripura R, von Seidlein L, Nguon C, Davoeung C, Day NPJ, Dondorp AM, White NJ.

J Infect Dis. 2019 Feb 15;219(5):695-702. doi: 10.1093/infdis/jiy519.

40.

Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway.

Ye W, Chew M, Hou J, Lai F, Leopold SJ, Loo HL, Ghose A, Dutta AK, Chen Q, Ooi EE, White NJ, Dondorp AM, Preiser P, Chen J.

PLoS Pathog. 2018 Oct 4;14(10):e1007298. doi: 10.1371/journal.ppat.1007298. eCollection 2018 Oct.

41.

Fitness Loss under Amino Acid Starvation in Artemisinin-Resistant Plasmodium falciparum Isolates from Cambodia.

Bunditvorapoom D, Kochakarn T, Kotanan N, Modchang C, Kümpornsin K, Loesbanluechai D, Krasae T, Cui L, Chotivanich K, White NJ, Wilairat P, Miotto O, Chookajorn T.

Sci Rep. 2018 Aug 22;8(1):12622. doi: 10.1038/s41598-018-30593-5.

42.

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.

Chairat K, Jittamala P, Hanboonkunupakarn B, Pukrittayakamee S, Hanpithakpong W, Blessborn D, White NJ, Day NPJ, Tarning J.

J Antimicrob Chemother. 2018 Nov 1;73(11):3102-3113. doi: 10.1093/jac/dky297.

43.

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.

Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, Chu CS, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Gonzalez-Ceron L, Grigg MJ, Heidari A, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Nosten F, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Sutanto I, Taylor WRJ, Thwaites G, Tran BQ, Tran HT, Valecha N, Vieira JLF, Wangchuk S, William T, Woodrow CJ, Zuluaga-Idarraga L, Guerin PJ, White NJ, Price RN.

Lancet Infect Dis. 2018 Sep;18(9):1025-1034. doi: 10.1016/S1473-3099(18)30348-7. Epub 2018 Jul 20.

44.

Epidemiology of Plasmodium vivax Malaria Infection in Nepal.

Rijal KR, Adhikari B, Ghimire P, Banjara MR, Hanboonkunupakarn B, Imwong M, Chotivanich K, Ceintury KP, Lal BK, Das Thakur G, Day NPJ, White NJ, Pukrittayakamee S.

Am J Trop Med Hyg. 2018 Sep;99(3):680-687. doi: 10.4269/ajtmh.18-0373. Epub 2018 Jul 12.

45.

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias.

Saralamba N, Mayxay M, Newton PN, Smithuis F, Nosten F, Archasuksan L, Pukrittayakamee S, White NJ, Day NPJ, Dondorp AM, Imwong M.

Malar J. 2018 Jul 16;17(1):269. doi: 10.1186/s12936-018-2413-3.

46.

Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.

Tun KM, Jeeyapant A, Myint AH, Kyaw ZT, Dhorda M, Mukaka M, Cheah PY, Imwong M, Hlaing T, Kyaw TH, Ashley EA, Dondorp A, White NJ, Day NPJ, Smithuis F.

Malar J. 2018 Jul 11;17(1):258. doi: 10.1186/s12936-018-2404-4.

47.

Thromboelastometric prediction of mortality using the kinetics of clot growth in critically ill septic patients.

Scărlătescu E, Lancé MD, White NJ, Tomescu DR.

Blood Coagul Fibrinolysis. 2018 Sep;29(6):533-539. doi: 10.1097/MBC.0000000000000757.

PMID:
29985193
48.

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

Henriques G, Phommasone K, Tripura R, Peto TJ, Raut S, Snethlage C, Sambo I, Sanann N, Nguon C, Adhikari B, Pongvongsa T, Imwong M, von Seidlein L, Day NP, White NJ, Dondorp AM, Newton P, Ley B, Mayxay M.

Malar J. 2018 Jun 22;17(1):243. doi: 10.1186/s12936-018-2390-6.

49.

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.

Kloprogge F, Workman L, Borrmann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Mårtensson A, Ngasala B, Björkman A, Ashton M, Friberg Hietala S, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Barnes KI, Tarning J.

PLoS Med. 2018 Jun 12;15(6):e1002579. doi: 10.1371/journal.pmed.1002579. eCollection 2018 Jun.

50.

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.

Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, Raksapraidee R, Carrara VI, Bancone G, Watson J, Moore KA, Wiladphaingern J, Proux S, Sriprawat K, Winterberg M, Cheah PY, Chue AL, Tarning J, Imwong M, Nosten F, White NJ.

Clin Infect Dis. 2018 Oct 30;67(10):1543-1549. doi: 10.1093/cid/ciy319.

Supplemental Content

Loading ...
Support Center